SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Morepen Laboratories - Quaterly Results

05 May 2022 Evaluate
The Sales for the quarter ended March 2022 of Rs. 3424.42 millions rose by 29.66% from Rs. 2641.05 millions.Net Profit of the company move down -43.23% to Rs. 142.75  millions from Rs. 251.44 millions  in the same quarter last year.The Operating Profit of the company witnessed a decrease to 222.87 millions from 315.21 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 3424.42 2641.05 29.66 14492.67 11124.23 30.28 14492.67 11124.23 30.28
Other Income 31.08 38.68 -19.65 102.35 117.74 -13.07 102.35 117.74 -13.07
PBIDT 222.87 315.21 -29.29 1393.72 1241.47 12.26 1393.72 1241.47 12.26
Interest 7.96 -0.54 -1574.07 -73.66 17.88 -511.97 -73.66 17.88 -511.97
PBDT 214.91 315.75 -31.94 1467.38 1223.59 19.92 1467.38 1223.59 19.92
Depreciation 48.20 64.31 -25.05 211.95 281.10 -24.60 211.95 281.10 -24.60
PBT 166.71 251.44 -33.70 1255.43 942.49 33.20 1255.43 942.49 33.20
TAX 23.96 0.00 0.00 244.81 0.00 0.00 244.81 0.00 0.00
Deferred Tax 24.83 0.00 0.00 24.83 0.00 0.00 24.83 0.00 0.00
PAT 142.75 251.44 -43.23 1010.62 942.49 7.23 1010.62 942.49 7.23
Equity 955.59 899.59 6.23 955.59 899.59 6.23 955.59 899.59 6.23
PBIDTM(%) 6.51 11.94 -45.47 9.62 11.16 -13.83 9.62 11.16 -13.83

Morepen Laboratories Share Price

41.92 0.79 (1.92%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×